prevention of lymphedema after breast cancer surgery
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2019/07/020436
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Women above the age of 18 years with metastatic palpable axillary lymph nodes confined to level 1 with invasive breast cancer in the ipsilateral breast.
2.Locally advanced breast cancer patients who have received neoadjuvant chemotherapy.( T3N0,T3N1, )
1.Women with inflammatory breast cancer, skin involvement and chest wall involvement as they should undergo complete axillary lymph node dissection.
2.Pregnant women
3.Lactating women
4.Women refusing to sign consent form.
5.Patients allergic to injection Benzathine penicillin
6.Patients with advanced disease including N3, and metastatic disease.
7.Upper limb swelling with deep vein thrombosis
8.Acute infections of upper limb.
9.Refusals for consent for randomization or long follow up.
10.Patients with established upper limb lymphedema. (Pre operative difference of >2cm in both upper limbs circumference)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method